The p21 region of human chromosome 9 is thought to contain a gene (MLM) involved in genetic susceptibility to melanoma and a gene or genes that influence progression of certain other tumors. Genomic clones that span a large region in 9p21 surrounding the presumptive tumor suppressor gene(s) have been isolated. A set of sequence-tagged sites in this region has been developed. By using these markers and others previously reported, the 9p21 region has been studied by physical mapping in 84 melanoma cei lines. A putative tumor suppressor gene, perhaps MLM itself, has been localized to a region of less than 40 kb that lies proximal (centromeric) to the a-interferon gene duster.
The incidence of melanoma is increasing at a rate second only to the rate of lung cancer in females. Approximately 32,000 new cases of cutaneous malignant melanoma were diagnosed in the United States in 1992, and although the disease is readily treatable in its early stages, it causes 7000 deaths in the U.S. per year at present (1) . A considerable portion ofthe incidence of melanoma can be attributed to environmental factors such as exposure to sunlight (2) . However, extensive studies of melanoma-prone families have shown that susceptibility to melanoma is controlled in part by a locus known as MLM on the short arm of chromosome 9 in humans (3) (4) (5) . Melanoma predisposition in these families is inherited as a dominant Mendelian trait closely linked to the a-interferon gene family.
MLM or a closely linked locus may be involved in the genesis of tumors other than melanoma. Cytogenetic and/or molecular abnormalities in the vicinity of MLM have been characterized in glioma cell lines (6) , non-small cell lung lines (7, 8) , and acute lymphoblastic leukemia lines (9, 10) . These abnormalities include chromosomal translocations, inversions, heterozygous deletions, and homozygous deletions. Whether or not MLM contributes to heritable predisposition to cancers other than melanoma is unclear. However, based on the frequency of 9p21 chromosomal abnormalities in nonmelanoma tumor cells, it is probable that the MLM region contains a gene (or genes) that participates at least in the progression of several different tumor types.
To characterize the MLM region further, we studied a large set of genetic markers and sequence-tagged sites (STSs). These studies enabled us to (i) develop a physical map of the region, (ii) (12) .
P1 clones spanning the MLM region were obtained from Genome Systems, St. Louis, by screening with STSs that we provided. DNA from these clones was isolated by alkaline lysis (13) followed by cesium chloride gradient centrifugation (12) .
Generation of STSs. STSs were generated by sequencing 1 (Fig. 1) . Three of the YAC clones (C9, C6, and F9) were subcloned into A phage and one YAC (C6) was subcloned into a cosmid vector. These A and cosmid clones provided a convenient way to produce STSs internal to known genetic markers and to expedite the chromosomal walk described below.
To provide an independent source of genomic DNA for construction of a contiguous genomic map of the region and to aid in production of STSs, we initiated a chromosomal walk in P1 clones from IFNA-s extending toward D9S171, from D9S171 extending back toward IFNA-s, and from the two ends of YAC C6, a nonchimeric YAC, in both directions. A total of 27 P1 clones were isolated as part of this chromosomal walk (Fig. 1) 
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